|
|
|
|
|
by continuational
2183 days ago
|
|
I don't really understand the outrage. Surely, the price is only too high in the event that they can't sell their product? It's a business, not a charity. Other companies will be looking hungrily at these earnings and invest in developing their own antivirals---which is exactly the desired outcome. Sure, it would be great to have this drug available to everyone right here, right now, for cheap. But investing on those terms is not very attractive; hence the drug simply wouldn't exist. |
|